GENEVA, July 19 -- HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. (No. 866, Moganshan Road, Gongshu DistrictHangzhou, Zhejiang 310011), 杭州中美华东制药有限公司 (中国浙江省杭州市拱墅区莫干山路866号) filed a patent application (PCT/CN2025/071771) for "PHARMACEUTICAL COMPOSITION OF LONG-ACTING GLP-1/GIP DUAL AGONIST" on Jan 10, 2025. With publication no. WO/2025/149039, the details related to the patent application was published on Jul 17, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the ...